Sign in

CIK 0001176309

  • Non-accelerated filer
  • Smaller reporting company

ORAMED PHARMACEUTICALS INC.

Sign in to watch
Ticker
ORMP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
980376008
Phone
+1 646-844-1164
Business address
1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK, NY, 10036
Former names
Integrated Security Technologies, Inc., IGUANA VENTURES LTD
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$225,530
in 2 filings, $226K under 10b5-1 plans

Net −$225,530. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 59 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-11-12 KIDRON NADAV President and CEO Grant or award +629,000 4,769,505
2026-11-12 KIDRON NADAV President and CEO Grant or award +688,000 5,457,505
2026-09-24 KIDRON NADAV President and CEO Grant or award +349,497 3,771,740
2026-09-24 KIDRON NADAV President and CEO Grant or award +368,765 4,140,505
2026-09-24 KIDRON NADAV President and CEO Returned to the company · Stock option (right to buy) −196,500 0
2026-09-24 KIDRON NADAV President and CEO Returned to the company · Stock option (right to buy) −190,000 0
2026-09-24 KIDRON NADAV President and CEO Returned to the company · Stock option (right to buy) −49,000 0
2026-09-24 KIDRON NADAV President and CEO Returned to the company · Stock option (right to buy) −97,000 0
2026-09-24 KIDRON NADAV President and CEO Returned to the company · Stock option (right to buy) −150,000 0
2026-09-24 KIDRON NADAV President and CEO Returned to the company · Stock option (right to buy) −107,000 0
2026-03-30 KIDRON NADAV President and CEO Shares withheld for taxes −44,818 $3.31 $148K 3,422,243
2026-03-17 KIDRON NADAV President and CEO Grant or award +167,005 3,422,243
2026-03-12 KIDRON NADAV President and CEO Gift −100,000 3,255,238
2026-01-22 KIDRON NADAV President and CEO Option exercise +109,000 3,355,238
2026-01-22 KIDRON NADAV President and CEO Option exercise · Performance Stock Units −109,000 0
2025-12-31 KIDRON NADAV President and CEO Grant or award +232,640 2,919,238
2025-12-31 KIDRON NADAV President and CEO Grant or award +327,000 3,246,238
2025-12-31 KIDRON NADAV President and CEO Grant or award · Performance Stock Units +109,000 109,000
2025-02-11 KIDRON NADAV President and CEO Grant or award +141,000 2,400,598
2025-02-11 KIDRON NADAV President and CEO Grant or award +186,000 2,586,598

Page 1 of 4 · 70 trades